Jessica Gatliff, MD
Urogynecology and Reconstructive Pelvic Surgery · Knoxville, TNNPI 1710140124
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,197 of the $1,956 with a category attached, or 61.2%. 10 manufacturers reported payments, led by Valencia Technologies Corporation at 35.0% of the total. Reporting peaked in 2023 at $914 and has fallen 58.8% since, to $377 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in TN, where the typical reported total is $5,304.
Across 27 payments — averaging $72.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Valencia Technologies Corporation$685
- Medtronic$601
- Sumitomo Pharma America, Inc.$188
- AbbVie$134
- Boston Scientific$114
- Cook Medical LLC$111
- plus $124 from 4 others
Across 1 payment — averaging $887.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$888
What the payments were for
- Travel & lodging$1,19761%
- Food & beverage$75939%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Valencia Technologies Corporation | 3 | $685 |
| Medtronic | 4 | $601 |
| Sumitomo Pharma America, Inc. | 4 | $188 |
| AbbVie | 8 | $134 |
| Boston Scientific | 2 | $114 |
| Cook Medical LLC | 1 | $111 |
| Grifols USA, LLC | 2 | $46 |
| Laborie Medical Technologies Corp. | 1 | $38 |
| AstraZeneca | 1 | $20 |
| Olympus America Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- eCoin Device Kit$643
- RESONANCE$111
- GEMTESA$102
How this compares
$1,956 in reported general payments places this provider in the 20th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Tennessee.
See all urogynecology and reconstructive pelvic surgery providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 162 | $109,894 |
| MyrbetriqMirabegron | 168 | $95,791 |
| Estradiol | 181 | $14,419 |
| Trospium Chloride ErTrospium Chloride | 46 | $9,518 |
| Methenamine Hippurate | 75 | $4,697 |
| Trospium Chloride | 33 | $839 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 61 | $691 |
| Trimethoprim | 13 | $460 |
| Clobetasol Propionate | 12 | $400 |
| Oxybutynin Chloride | 13 | $289 |
| Cephalexin | 43 | $204 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $125 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $90 |
| Levofloxacin | 16 | $51 |
| Fluconazole | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $188 | $109,894162 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Tennessee.
Other urogynecology and reconstructive pelvic surgery in Knoxville
- C BowlingKnoxville$52K
- Michael PolinKnoxville$2K
- Robert ElderKnoxville$383
- Tara AllenNashville$100K
- Barry JarnaginFranklin$57K
- Rena AzarSouth Pittsburg$23K
- Marcy AbelNashville$22K
- Roland HuffakerJohnson City$17K
- Henry OkaforChattanooga$13K
- Carson KaeserChattanooga$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.